Insider Transactions
| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Jun 03, 2022 |
Director
Trans History: 3
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 27,353 | -- | 93,239 |
| Jun 03, 2022 |
Director
Trans History: 112
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 27,353 | -- | 245,466 |
| Jun 03, 2022 |
Director
Trans History: 125
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 27,353 | -- | 179,482 |
| Mar 24, 2022 |
Director
Trans History: 9
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 90,000 | $4.40 | 128,089 |
| Aug 20, 2021 |
Director
Trans History: 9
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 65,886 | -- | 218,089 |
| Aug 20, 2021 |
Director
Trans History: 9
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 65,885 | -- | 65,885 |
| Aug 20, 2021 |
CCO & CIO
Trans History: 8
|
CCO & CIO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 392,175 | -- | 431,862 |
| Aug 20, 2021 |
CCO & CIO
Trans History: 8
|
CCO & CIO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 392,175 | -- | 392,175 |
| Aug 20, 2021 |
CHRO
Trans History: 7
|
CHRO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 112,500 | -- | 139,249 |
| Aug 20, 2021 |
CHRO
Trans History: 7
|
CHRO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 112,500 | -- | 112,500 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.